P2RX7 and graft versus host disease: The involvement of P2X7 in GVHD pathophysiology and progression has been shown in a humanised mouse model using small molecule antagonists7, 8, 9 and a species‐specific anti‐human (h) P2X7 monoclonal antibody (mAb).10